Immune signature as predictive marker for response to checkpoint inhibitor immunotherapy and overall survival in melanoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Identifier
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Cancer medicine. 10. 5. 2021. 1562. 1575. -
- Ereignis
-
Veröffentlichung
- (wo)
-
Mainz
- (wer)
-
Universitätsbibliothek der Johannes Gutenberg-Universität Mainz
- (wann)
-
2021
- Urheber
-
Krebs, Franziska K.
Trzeciak, Emily R.
Zimmer, Sophia
Özistanbullu, Deniz
Mitzel-Rink, Heidrun
Meissner, Markus
Grabbe, Stephan
Loquai, Carmen
Tüttenberg, Andrea
- DOI
-
10.25358/openscience-5907
- Handle
- URN
-
urn:nbn:de:101:1-2022020313282609276891
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Krebs, Franziska K.
- Trzeciak, Emily R.
- Zimmer, Sophia
- Özistanbullu, Deniz
- Mitzel-Rink, Heidrun
- Meissner, Markus
- Grabbe, Stephan
- Loquai, Carmen
- Tüttenberg, Andrea
- Universitätsbibliothek der Johannes Gutenberg-Universität Mainz
Entstanden
- 2021
Ähnliche Objekte (12)
Gene signature from cutaneous autoimmune diseases provides potential immunotherapy-relevant biomarkers in melanoma
Immunotherapy of malignant melanoma
Checkpoint inhibition immunotherapy for advanced local and systemic conjunctival melanoma: a clinical case series
Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma?
Cancer immunotherapy beyond immune checkpoint inhibitors
PANoptosis-related prognostic signature predicts overall survival of cutaneous melanoma and provides insights into immune infiltration landscape
Metastatic melanoma to small bowel: metastasectomy is supported in the era of immunotherapy and checkpoint inhibitors
Immune checkpoint inhibitors for multiple myeloma immunotherapy
Comprehensive analysis identifies IFI16 as a novel signature associated with overall survival and immune infiltration of skin cutaneous melanoma
Beyond PD-1 Immunotherapy in Malignant Melanoma
Advances in predictive biomarkers for melanoma immunotherapy
The age of enlightenment in melanoma immunotherapy
Gene signature from cutaneous autoimmune diseases provides potential immunotherapy-relevant biomarkers in melanoma
Immunotherapy of malignant melanoma
Checkpoint inhibition immunotherapy for advanced local and systemic conjunctival melanoma: a clinical case series
Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma?
Cancer immunotherapy beyond immune checkpoint inhibitors
PANoptosis-related prognostic signature predicts overall survival of cutaneous melanoma and provides insights into immune infiltration landscape
Metastatic melanoma to small bowel: metastasectomy is supported in the era of immunotherapy and checkpoint inhibitors
Immune checkpoint inhibitors for multiple myeloma immunotherapy
Comprehensive analysis identifies IFI16 as a novel signature associated with overall survival and immune infiltration of skin cutaneous melanoma
Beyond PD-1 Immunotherapy in Malignant Melanoma
Advances in predictive biomarkers for melanoma immunotherapy
The age of enlightenment in melanoma immunotherapy
Gene signature from cutaneous autoimmune diseases provides potential immunotherapy-relevant biomarkers in melanoma
Immunotherapy of malignant melanoma
Checkpoint inhibition immunotherapy for advanced local and systemic conjunctival melanoma: a clinical case series
Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma?
Cancer immunotherapy beyond immune checkpoint inhibitors
PANoptosis-related prognostic signature predicts overall survival of cutaneous melanoma and provides insights into immune infiltration landscape
Metastatic melanoma to small bowel: metastasectomy is supported in the era of immunotherapy and checkpoint inhibitors
Immune checkpoint inhibitors for multiple myeloma immunotherapy
Comprehensive analysis identifies IFI16 as a novel signature associated with overall survival and immune infiltration of skin cutaneous melanoma
Beyond PD-1 Immunotherapy in Malignant Melanoma
Advances in predictive biomarkers for melanoma immunotherapy